Funders › NY › Target Als Foundation Inc › 2021
Grants paid by Target Als Foundation Inc, tax year 2021
EIN 81-0756743 · New York, NY · Form 990-PF, Part XV · NTEE B82
In tax year 2021, Target Als Foundation Inc (EIN 81-0756743) reported 25 grants paid totaling $5,886,581. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2021
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2021 | Washington University St Louis, MO | B | $843,491 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Dignity Health - St Joseph's Hospital and Medical Center Phoenix, AZ | U | $481,412 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Massachusetts General Hospital Boston, MA | C | $393,634 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | University of Massachusetts Medical School Worcester, MA | U | $357,800 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Johns Hopkins University Baltimore, MD | U | $350,000 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | University of California San Diego La Jolla, CA | U | $311,972 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Georgetown University Medical Center Washington, DC | D | $288,140 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Mayo Clinic - Jacksonville Florida Jacksonville, FL | U | $262,325 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Ac Immune Sa Lausanne | U | $260,000 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Centre Hospitalier de Universite de Montreal Montreal | U | $233,500 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | University of Pittsburgh Pittsburgh, PA | B | $200,000 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Expansion Therapeutics Inc Jupiter, FL | U | $200,000 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Vlaams Instituut Voor Biotechnolgie Gent | U | $200,000 | paid | BIOMEDICAL REASEARCH | 202201249349101130 |
| 2021 | Scripps Research La Jolla, CA | U | $200,000 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | University of Pennsylvania Philadelphia, PA | U | $200,000 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Novation Pharmaceutical Inc Port Coquilam, BRITISH COLUMBIA | U | $199,176 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Harvard University Cambridge, MA | C | $180,000 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | University of Michigan Ann Arbor, MI | U | $177,800 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | New York Genome Center New York, NY | B | $111,318 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Universitaire Ziekenhuizen Leuven Leuven | U | $100,000 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Eikonizo Therapeutics Inc Cambridge, MA | U | $100,000 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Quralis Cambridge, MA | U | $90,000 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Temple University Philadelphia, PA | U | $77,013 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Biogen Cambridge, MA | U | $44,000 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
| 2021 | Vivid Sciences Minneapolis, MN | U | $25,000 | paid | BIOMEDICAL RESEARCH | 202201249349101130 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.